Fig. 6From: CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignanciesCDC20 alterations across hemato-oncological patients. A Frequency and distribution of CDC20 mutations and copy number alterations (CAN) in hematological malignancies. B Effect of CNA on CDC20 mRNA level in AML and DLBCL casesBack to article page